Department of Surgery, Swiss Hepato-Pancreatico-Biliary Center, University Hospital Zurich, Zurich, Switzerland.
Gut. 2012 Jan;61(1):117-27. doi: 10.1136/gutjnl-2011-300155. Epub 2011 Oct 13.
The purpose of this study was to assess non-invasive imaging modalities including MRI and CT and compare the quantitative amount of fat with data provided by the pathologist and a chemical lipid assay in leptin-deficient mouse livers.
A liver/fat phantom was first used to assess the accuracy of small-animal MRI and human MRI and CT, followed by correlation analysis with ob/ob mouse liver fat quantified by an accurate chemical lipid assay. Similarly, the authors compared the pathologist's quantification and the automated software quantification of fat with the lipid assay. The authors then investigated whether hepatic steatosis assessed by MRI correlates with the degree of liver injury in a model of ischaemia/reperfusion in leptin-deficient mice as well as with serious postoperative complications in patients undergoing major liver resection (NCT01234714).
The authors designed lipid/liver mixtures at various ratios to mimic a wide range of fat liver contents. Small-animal and human MRI detected this fat with a high correlation to the actual fat contents. Mouse livers assessed by human MRI correlated best with total intrahepatic fat by chemical lipid analysis (r=0.975). Human CT, the pathologist's assessment and the automated software were less reliable (r=-0.873, 0.512 and 0.873, respectively). There was a significant correlation of the MRI fat quantification with several parameters of liver injury, and MRI data could predict mouse survival after ischaemia/reperfusion injury. In patients undergoing major liver resection, higher liver fat content was associated with more serious postoperative complications, such as liver or multiorgan failure and sepsis, necessitating admission to the intensive care unit.
With the use of a well-defined set of biological standards, MRI can predict intrahepatic fat with high accuracy. In contrast to biopsies, this method is non-invasive, giving a representative assessment of the whole liver.
本研究旨在评估包括 MRI 和 CT 在内的非侵入性成像方式,并将其与瘦素缺乏型小鼠肝脏的病理学家数据和化学脂质分析所提供的定量脂肪进行比较。
首先使用肝脏/脂肪模型来评估小动物 MRI 和人体 MRI 和 CT 的准确性,然后与通过准确的化学脂质分析定量的 ob/ob 小鼠肝脏脂肪进行相关性分析。同样,作者还比较了病理学家和自动软件对脂肪的定量与脂质分析的结果。作者随后研究了 MRI 评估的肝脂肪变性是否与瘦素缺乏型小鼠缺血/再灌注模型中的肝损伤程度以及接受大肝切除术的患者的严重术后并发症(NCT01234714)相关。
作者设计了不同比例的脂质/肝脏混合物来模拟广泛的脂肪肝脏含量。小动物和人体 MRI 以高相关性检测到这些脂肪。人体 MRI 评估的小鼠肝脏与化学脂质分析的总肝内脂肪相关性最好(r=0.975)。人体 CT、病理学家评估和自动软件的可靠性较差(r=-0.873、0.512 和 0.873)。MRI 脂肪定量与肝损伤的几个参数有显著相关性,MRI 数据可以预测缺血/再灌注损伤后小鼠的存活率。在接受大肝切除术的患者中,较高的肝脂肪含量与更严重的术后并发症相关,如肝或多器官衰竭和败血症,需要入住重症监护病房。
使用明确的生物学标准集,MRI 可以以高精度预测肝内脂肪。与活检相比,这种方法是非侵入性的,可以对整个肝脏进行代表性评估。